Center for Scientific Review; Notice of Closed Meetings, 10526-10527 [2023-03491]
Download as PDF
<![CDATA[
10526
Federal Register / Vol. 88, No. 34 / Tuesday, February 21, 2023 / Notices
Dated: February 15, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–03521 Filed 2–17–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Request for Information on Promising
Practices for Advancing Health Equity
for Intersex Individuals; Correction
ACTION:
Notice; correction.
The Office of the Assistant
Secretary for Health published a
document in the Federal Register of
February 10, 2023, announcing a request
for information on Promising Practices
for Advancing Health Equity for Intersex
Individuals. The document included
incorrect information regarding the
ADDRESSES section and also
SUPPLEMENTARY INFORMATION and also
the collection for public comment.
FOR FURTHER INFORMATION CONTACT:
Adrian Shanker, Adrian.shanker@
hhs.gov or by phone at (202) 961–6483.
SUPPLEMENTARY INFORMATION:
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
Correction
In the Federal Register of February
10, 2023, in FR Doc 2023–02826, on
page 8876 in the first column, correct
the ADDRESSES section to read, ‘‘Please
see the supplementary information to
view the questions. Comments must be
submitted via Regulations.gov. Mailed
paper and emailed submissions will not
be reviewed.’’
At the second column, tenth line,
after the end of the sentence
‘‘conversation therapy.’’ the sentence
should continue with the following:
‘‘(efforts to change an individual’s
sexual orientation, gender identity, or
gender expression, a practice not
supported by any credible evidence that
has been rejected and disavowed by
behavioral health experts and
associations). Conversion therapy
perpetuates outdated views of gender
roles and identities as well as the
negative stereotype that being a sexual
or gender minority or identifying as
LGBTQI+ is an abnormal aspect of
human development. Most importantly,
it may put young people at risk of
serious harm.’’
At the second column, second
paragraph to the end of the document is
to be replaced as follows: ‘‘Request for
Comments on the Report Development
on Promising Practices for Advancing
Health Equity for Intersex Individuals:
The OASH invites input from intersex
people, stakeholders throughout the
VerDate Sep<11>2014
17:54 Feb 17, 2023
Jkt 259001
scientific research community, clinical
and behavioral practice communities,
patient and family advocates, school
and university-based campus health
care providers, persons from rural and
frontier areas, scientific or professional
organizations, federal partners, internal
HHS stakeholders, and other interested
members of the public on the two
questions highlighted below. This input
will serve as a valuable element in the
development of the report, and the
community’s time and consideration are
highly appreciated.
• What do you see as the current
clinical/behavioral, research, services,
and/or policy gaps that you are hoping
this report addresses?
• What recent or ongoing research,
innovative clinical/behavioral
approaches and/or policy actions do
you think are important for us to know
about as we begin this work?
• What are the barriers to intersex
individuals receiving clinical/
behavioral care? Are there innovative
policies or practices that overcome such
barriers?
• What are the social factors that
impact clinical/behavioral care (e.g., the
medical community’s perceptions or
biases around sex/gender) and how do
these impact delivery and quality of
care for intersex individuals?
• What promising practices for
advancing health equity for intersex
individuals should we be aware of?
Responses to this RFI are voluntary.
Do not include any personally
identifiable, proprietary, classified,
confidential, trade secret, or sensitive
information in your response. The
responses will be reviewed by OASH
staff, and individual feedback will not
be provided to any responder. The
Government will use the information
submitted in response to this RFI at its
discretion. The Government reserves the
right to release comments publicly and
to use any submitted information on
public HHS websites; in reports; in
summaries of the state of the science; in
any possible resultant solicitation(s),
grant(s), or cooperative agreement(s); or
in the development of future funding
opportunity announcements.
This RFI is for information and
planning purposes only and should not
be construed as a solicitation for
applications or proposals, or as an
obligation in any way on the part of the
United States Federal Government, the
HHS, or individual HHS Agencies and
Offices to provide support for any ideas
identified in response to it. The Federal
Government will not pay for the
preparation of any information
submitted or for the Government’s use
of such information.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
No basis for claims against the U.S.
Government shall arise as a result of a
response to this RFI or from the
Government’s use of such information.
Additionally, the Government cannot
guarantee the confidentiality of the
information provided.’’
Dated: February 15, 2023.
Rachel L. Levine,
Assistant Secretary for Health.
[FR Doc. 2023–03539 Filed 2–17–23; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Chemistry, Biochemistry and
Biophysics A.
Date: March 14–15, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vandana Kumari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496–3290,
vandana.kumari@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
HEAL Initiative—Helping to End Addiction
Long-term.
Date: March 14, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Erik Pollio, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F,
Bethesda, MD 20892, (301) 594–4002,
polliode@csr.nih.gov.
E:\FR\FM\21FEN1.SGM
21FEN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 34 / Tuesday, February 21, 2023 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; NIH
Director’s New Innovator Award Program
(DP2).
Date: March 15–16, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Eugene Carstea, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4130,
MSC 7818, Bethesda, MD 20892, (301) 408–
9756, carsteae@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrine and Metabolic Systems.
Date: March 15, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Baskaran Thyagarajan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 800B,
Bethesda, MD 20892, (301) 867–5309,
thyagarajanb2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA/
REAP: Cardiovascular and Respiratory
Sciences.
Date: March 16, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Margaret Chandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126,
MSC 7814, Bethesda, MD 20892, (301) 435–
1743, margaret.chandler@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Medical Imaging.
Date: March 16–17, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Krystyna H. Szymczyk,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4198, szymczykk@
csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
Cellular and Molecular Immunology—A
Study Section.
Date: March 16–17, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:54 Feb 17, 2023
Jkt 259001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammad Samiul Alam,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809D,
Bethesda, MD 20892, (301) 435–1199,
alammos@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Cancer Immunology and
Immunotherapy II.
Date: March 16–17, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ola Mae Zack Howard,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7806, Bethesda, MD 20892, 301–451–
4467, howardz@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Cellular Mechanism of Hallmarks of Aging.
Date: March 16–17, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J,
Bethesda, MD 20892, (301) 435–1042,
zakam2@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Transplantation, Tolerance, and Tumor
Immunology Study Section.
Date: March 16–17, 2023.
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Carmen Angeles UfretVincenty, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 594–0912,
carmen.ufret-vincenty@nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
HIV Immunopathogenesis and Vaccine
Development Study Section.
Date: March 16–17, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
10527
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Radiation Therapeutics and Biology.
Date: March 16, 2023.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gloria Huei-Ting Su,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, sug2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Hepatology and
Environmental Toxicology.
Date: March 17, 2023.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aster Juan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, 301–435–5000, juana2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Sensory Motor Neurobiology.
Date: March 17, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sepandarmaz Aschrafi,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040D,
Bethesda, MD 20892, (301) 451–4251,
Armaz.aschrafi@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 14, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–03491 Filed 2–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Chimpanzee Research Use
Form (Office of the Director)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
E:\FR\FM\21FEN1.SGM
Notice.
21FEN1
]]>Agencies
[Federal Register Volume 88, Number 34 (Tuesday, February 21, 2023)]
[Notices]
[Pages 10526-10527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03491]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Chemistry, Biochemistry and Biophysics A.
Date: March 14-15, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vandana Kumari, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496-3290, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: HEAL Initiative--Helping to End Addiction Long-
term.
Date: March 14, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Erik Pollio, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F, Bethesda, MD 20892, (301)
594-4002, [email protected].
[[Page 10527]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; NIH Director's New Innovator Award Program (DP2).
Date: March 15-16, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Eugene Carstea, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4130, MSC 7818, Bethesda, MD
20892, (301) 408-9756, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Endocrine and Metabolic Systems.
Date: March 15, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Baskaran Thyagarajan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 800B, Bethesda, MD 20892, (301)
867-5309, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AREA/REAP: Cardiovascular and Respiratory Sciences.
Date: March 16, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Margaret Chandler, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126, MSC 7814, Bethesda, MD
20892, (301) 435-1743, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Medical Imaging.
Date: March 16-17, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Krystyna H. Szymczyk, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-4198,
[email protected].
Name of Committee: Infectious Diseases and Immunology A
Integrated Review Group; Cellular and Molecular Immunology--A Study
Section.
Date: March 16-17, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammad Samiul Alam, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809D, Bethesda, MD 20892, (301)
435-1199, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Cancer Immunology and Immunotherapy II.
Date: March 16-17, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD
20892, 301-451-4467, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Cellular Mechanism of Hallmarks of Aging.
Date: March 16-17, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; Transplantation, Tolerance, and Tumor
Immunology Study Section.
Date: March 16-17, 2023.
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Carmen Angeles Ufret-Vincenty, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0912,
[email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; HIV Immunopathogenesis and Vaccine
Development Study Section.
Date: March 16-17, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD
20892, 301-443-5779, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Radiation Therapeutics and Biology.
Date: March 16, 2023.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gloria Huei-Ting Su, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Hepatology and Environmental
Toxicology.
Date: March 17, 2023.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aster Juan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20817, 301-435-5000,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Sensory Motor Neurobiology.
Date: March 17, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sepandarmaz Aschrafi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040D, Bethesda, MD 20892, (301)
451-4251, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 14, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-03491 Filed 2-17-23; 8:45 am]
BILLING CODE 4140-01-P
